The Avandia debate

被引:20
作者
Bloomgarden, Zachary T. [1 ]
机构
[1] Mt Sinai Sch Med, Div Endocrinol, New York, NY 10029 USA
关键词
PIOGLITAZONE CLINICAL-TRIAL; RANDOMIZED CONTROLLED-TRIAL; ARTERIAL-WALL THICKNESS; INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; MACROVASCULAR EVENTS; GLUCOSE CONTROL; ROSIGLITAZONE; OUTCOMES;
D O I
10.2337/dc07-zb09
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2401 / 2408
页数:8
相关论文
共 38 条
[1]   Interventional cardiology -: Peroxisome proliferator-activated receptor γ agonists for the Prevention of Adverse events following percutaneous coronary Revascularization -: results of the PPAR Study [J].
Bhatt, Deepak L. ;
Chew, Derek P. ;
Grines, Cindy ;
Mukherjee, Debabrata ;
Leesar, Massoud ;
Gilchrist, Ian C. ;
Corbelli, John C. ;
Blankenship, James C. ;
Eres, Avichai ;
Steinhubl, Steven ;
Tan, Walter A. ;
Resar, Jon R. ;
AlMahameed, Amjad ;
Abdel-Latif, Ahmed ;
Tang, Wilson ;
Brennan, Danielle ;
McErlean, Ellen ;
Hazen, Stanley L. ;
Topol, Eric J. .
AMERICAN HEART JOURNAL, 2007, 154 (01) :137-143
[2]   Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].
Buchanan, TA ;
Xiang, AH ;
Peters, RK ;
Kjos, SL ;
Marroquin, A ;
Goico, J ;
Ochoa, C ;
Tan, S ;
Berkowitz, K ;
Hodis, HN ;
Azen, SP .
DIABETES, 2002, 51 (09) :2796-2803
[3]   Rosiglitazone could improve clinical outcomes after coronary stent implantation in nondiabetic patients with metabolic syndrome [J].
Cao Zheng ;
Zhou Yu-jie ;
Zhao Ying-xin ;
Liu Yu-yang ;
Guo Yong-he ;
Cheng Wan-jun .
CHINESE MEDICAL JOURNAL, 2006, 119 (14) :1171-1175
[4]   Large trials vs meta-analysis of smaller trials - How do their results compare? [J].
Cappelleri, JC ;
Ioannidis, JPA ;
Schmid, CH ;
deFerranti, SD ;
Aubert, M ;
Chalmers, TC ;
Lau, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16) :1332-1338
[5]  
*COCHR COLL, 2002, THINGS YOU CAN DIV H
[6]   EasyMA: A program for the meta-analysis of clinical trials [J].
Cucherat, M ;
Boissel, JP ;
Leizorovicz, A ;
Haugh, MC .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1997, 53 (03) :187-190
[7]  
Diabetes Prevention Progam, 2005, DIABETES, V54, P1150
[8]   Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].
Dormandy, JA ;
Charbonnel, B ;
Eckland, DJA ;
Erdmann, E ;
Massi-Benedetti, M ;
Kmoules, IK ;
Skene, AM ;
Tan, MH ;
Lefébvre, PJ ;
Murray, GD ;
Standl, E ;
Wilcox, RG ;
Wlhelmsen, L ;
Betteridge, J ;
Birkeland, K ;
Golay, A ;
Heine, RJ ;
Korányi, L ;
Laakso, M ;
Mokán, M ;
Norkus, A ;
Pirags, V ;
Podar, T ;
Scheen, A ;
Scherbaum, W ;
Schernthaner, G ;
Schmitz, O ;
Skrha, J ;
Smith, U ;
Taton, J .
LANCET, 2005, 366 (9493) :1279-1289
[9]  
*DREAM, 2006, N ENGL J MED, V355
[10]  
*END SOC, 2007, END SOC STAT PROV RE